Journal article
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma
Abstract
Importance: Most patients with locally advanced hepatocellular carcinoma (HCC) recur within the liver following systemic therapy.
Objective: To determine whether stereotactic body radiation therapy (SBRT) improves outcomes in patients with locally advanced HCC compared with sorafenib alone.
Authors
Dawson LA; Winter KA; Knox JJ; Zhu AX; Krishnan S; Guha C; Kachnic LA; Gillin MT; Hong TS; Craig TD
Journal
JAMA Oncology, Vol. 11, No. 2, pp. 136–144
Publisher
American Medical Association (AMA)
Publication Date
February 1, 2025
DOI
10.1001/jamaoncol.2024.5403
ISSN
2374-2437